ARCHIVES

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 32 No. 46 | December 22, 2006

Download PDF Visit The Full Archive

Related Articles

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

In Brief: McIntyre To Replace Frei As Group Chairman Abeloff, Murphy Nominated For ASCO Presidency

January 26, 1990

Barnett Kramer Retires From NIH

January 7, 2011

Kimes Calls Headline On DRG ‘Exaggerated Negativity’ In Letter

April 5, 1991

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005